ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

IMPV Imperva, Inc.

55.74
0.00 (0.00%)
Pre Market
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Imperva, Inc. NASDAQ:IMPV NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 55.74 45.00 199,999.99 0 00:00:00

Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Imperva, Inc. has obtained a Fair Price in its Sale to Thoma Br...

10/10/2018 4:41pm

PR Newswire (US)


Imperva, Inc. (NASDAQ:IMPV)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more Imperva, Inc. Charts.

MILWAUKEE, Oct. 10, 2018 /PRNewswire/ -- Ademi & O'Reilly, LLP is investigating the Board of Imperva Technologies Corporation (Nasdaq:IMPV) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Imperva to Thoma Bravo.

Click here to learn how to join the action: http://ademilaw.com/case/imperva or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.

Ademi & O'Reilly, LLP alleges Imperva's long-term financial outlook is improving and yet Imperva shareholders will receive the equivalent of only $55.75 for each share of Imperva common stock.  Thoma Bravo is well aware of Imperva's improving financial metrics and is purchasing Imperva at a substantial discount.  The merger agreement unreasonably limits competing bids for Imperva by (i) prohibiting solicitation of any further bids, and (ii) imposing a termination penalty should Imperva receive and accept a superior bid. Imperva insiders, their affiliates and other major shareholders own significant voting stock, and will receive millions of dollars as part of change of control arrangements, and therefore can unduly influence a sale of Imperva. Our investigation centers on the conduct of Imperva's Board of Directors, who have unanimously approved the transaction, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Imperva given its current financial condition and prospects.

If you own common stock in Imperva and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, or http://ademilaw.com/case/imperva.                   

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi & O'Reilly, LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Cision View original content:http://www.prnewswire.com/news-releases/shareholder-alert-ademi--oreilly-llp-investigates-whether-imperva-inc-has-obtained-a-fair-price-in-its-sale-to-thoma-bravo-llc-300728764.html

SOURCE Ademi & O'Reilly, LLP

Copyright 2018 PR Newswire

1 Year Imperva, Inc. Chart

1 Year Imperva, Inc. Chart

1 Month Imperva, Inc. Chart

1 Month Imperva, Inc. Chart

Your Recent History

Delayed Upgrade Clock